Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2659 |
|
Actual shortage: | 251 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2399 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
27 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-SERTRALINE | 50MG | CAPSULE | Resolved | 2021-04-15 | 2021-04-21 | 137547 |
ACT PIOGLITAZONE | 15MG | TABLET | Resolved | 2021-04-21 | 2022-04-28 | 137882 |
TEVA-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2021-04-21 | 2021-07-29 | 137885 |
DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2021-04-21 | 2021-05-20 | 137890 |
TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2021-04-21 | 2021-05-13 | 137893 |
TEVA-FLUOXETINE | 20MG | CAPSULE | Resolved | 2021-04-21 | 2021-06-03 | 137896 |
TEVA-LOSARTAN | 50MG | TABLET | Resolved | 2021-04-21 | 2024-04-01 | 137899 |
TEVA-LOSARTAN | 100MG | TABLET | Resolved | 2021-04-21 | 2024-04-01 | 137902 |
ACT PIOGLITAZONE | 30MG | TABLET | Resolved | 2021-04-21 | 2022-04-28 | 137905 |
TEVA-VALSARTAN | 160MG | TABLET | Resolved | 2021-04-22 | 2023-06-09 | 137936 |
ACT ESCITALOPRAM ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2021-04-29 | 2021-07-09 | 138282 |
TEVA-LENOLTEC NO. 2 | 15MG 15MG 300MG | TABLET | Resolved | 2021-04-29 | 2021-06-10 | 138285 |
TEVA-LENOLTEC NO. 3 | 300MG 30MG 15MG | TABLET | Resolved | 2021-04-29 | 2021-05-06 | 138288 |
TEVA-BUDESONIDE | 0.5MG | SUSPENSION | Resolved | 2021-04-29 | 2021-08-07 | 138291 |
TEVA-BUSPIRONE | 10MG | TABLET | Resolved | 2021-04-29 | 2021-05-13 | 138294 |
TEVA-CYPROTERONE / ETHINYL ESTRADIOL | 0.035MG 2MG | TABLET | Resolved | 2021-04-29 | 2021-09-02 | 138297 |
TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-04-29 | 2021-05-13 | 138300 |
TEVA-CAPTOPRIL | 50MG | TABLET | Resolved | 2021-04-29 | 2021-05-06 | 138303 |
TEVA-LOSARTAN | 25MG | TABLET | Resolved | 2021-04-29 | 2024-04-01 | 138306 |
TEVA-LOSARTAN | 50MG | TABLET | Resolved | 2021-04-29 | 2021-05-20 | 138309 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64855 |
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64858 |
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64861 |
TEVA-ENALAPRIL | 16MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64866 |
TEVA-ENALAPRIL | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64869 |
ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-19 | 2018-10-19 | 64891 |
TEVA-LISINOPRIL (TYPE P) | 5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64909 |
RATIO-TAMSULOSIN | 0.4MG | CAPSULE (SUSTAINED-RELEASE) | Discontinued | 2018-10-19 | 2018-10-19 | 64917 |
NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64923 |
TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64926 |
TEVA-CLONAZEPAM | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64929 |
TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64970 |
TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64975 |
TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64983 |
TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
TEVA-NORFLOXACIN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65013 |